by
Lauren Dubinsky, Senior Reporter | July 20, 2017
Expects other companies to
respect its patent rights
Medic Vision announced on Wednesday that its XR-29 Dose-Check system was granted a patent by the U.S. Patent and Trademark Office.
The SafeCT-29 product suite, which includes XR-29 Dose Check, was the first NEMA XR-29 third-party compliance solution to
receive FDA clearance in May 2016. To date, it has been installed in hundred of medical care centers throughout the U.S.
SafeCT-29 connects to the CT console and analyzes dose data in real time. The users are alerted before the scan if the estimated dose levels exceed the predefined dose limits, and scanning is automatically halted until the levels are changed or justified by the user.
Ad Statistics
Times Displayed: 173821
Times Visited: 3176 For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.
Eyal Aharon, CEO of Medic Vision, stated that when SafeCT-29 is added to existing CT systems, it provides compliance with the most challenging aspects of the XR-29 standard without requiring hospitals and imaging centers to purchase new CTs.
There are other third-party XR-29 compliance solutions on the market including Zetta Medical Technologies’ Z-Dose29, which
received FDA clearance in April. But Medic Vision maintains that it has the only solution endorsed by the OEMs.
In September 2016,
Philips Healthcare recommended SafeCT-29 to its non-compliant CT and PET/CT customers that were unable to become compliant through the OEM’s own upgrades.
Richardson Healthcare also recommended SafeCT-29 to its customers in August 2016.
Medic Vision believes that the issuance of the patent will significantly boost its market position. The company also stated that “it fully expects providers of medical imaging services and solutions to respect [its] patent rights.”
